HUMACYTE INC's ticker is and the CUSIP is 44486Q103. A total of 66 filers reported holding HUMACYTE INC in Q4 2021. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $3,237 | -58.6% | 1,132 | -55.2% | 0.00% | – |
| Q1 2023 | $7,811 | -27.7% | 2,528 | -50.6% | 0.00% | – |
| Q4 2022 | $10,807 | -65.1% | 5,122 | -47.0% | 0.00% | – |
| Q3 2022 | $31,000 | -8.8% | 9,670 | -9.4% | 0.00% | – |
| Q2 2022 | $34,000 | -57.0% | 10,670 | -4.8% | 0.00% | -100.0% |
| Q1 2022 | $79,000 | -16.8% | 11,213 | -14.7% | 0.00% | 0.0% |
| Q4 2021 | $95,000 | – | 13,150 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| York Capital Management Global Advisors, LLC | 2,291,397 | $16,177,000 | 4.71% |
| Endowment Wealth Management, Inc. | 96,618 | $682,000 | 0.72% |
| JOSH ARNOLD INVESTMENT CONSULTANT, LLC | 36,171 | $255,000 | 0.24% |
| Prescott General Partners LLC | 625,100 | $4,413,000 | 0.20% |
| CenterBook Partners LP | 45,752 | $323,000 | 0.12% |
| Gladstone Institutional Advisory LLC | 144,867 | $1,023 | 0.07% |
| Exos Asset Management LLC | 18,609 | $131,000 | 0.06% |
| Sciencast Management LP | 26,300 | $182,000 | 0.04% |
| Y-Intercept (Hong Kong) Ltd | 17,125 | $121,000 | 0.03% |
| Kovack Advisors, Inc. | 31,500 | $222,000 | 0.02% |